Qiagen N V (QGEN) Inventory Turnover Ratio, from fourth quarter 2025 to fourth quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Qiagen N v   (NYSE: QGEN)
 

Qiagen N V Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Qiagen N V 's inventory turnover ratio, the ratio that measures Qiagen N V 's ability to manage its supply chain, sequentially decreased to 2.73 in the fourth quarter 2025, which does not come as a surprise, as the Qiagen N V continue to experience headwinds, which also impact its supply chain. Qiagen N V 's average inventory processing period in the Dec 31 2025 quarter, has increased to 134 days, from 102 days, in the 0 quarter.

Within Healthcare sector 158 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 975 in the third quarter 2025, to 1442.

QGEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Qiagen N V Market Share?

What is Inventory Turnover Ratio?




QGEN Inventory Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Inventory Growth 10.07 % 8.1 % 8.1 % 8.1 % -27.6 %
Y / Y Cost of Sales Growth -22.79 % - - - 42.73 %
Inventory Turnover Ratio (TTM) 2.73 - - - 3.84
QGEN's Total Ranking # 1442 # 975 # # #
Average inventory processing period 133 - - - 95
Seq. Inventory Growth -43.92 % 0 % 0 % 96.27 % -44.92 %
Seq. Cost of Sales Growth - - - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 15
Healthcare Sector # 159
Overall Market # 1442

Inventory Turnover Ratio Statistics
High Average Low
5.35 3.4 1.9
(Dec 31 2021)   (Dec 31 2023)




Financial Statements
Qiagen N V 's Inventories $ 169 Millions Visit QGEN's Balance sheet
Qiagen N V 's Cost of Revenues TTM $ 735 Millions Visit QGEN's Income Statement
What are QGEN's Sales? Visit QGEN's Sales by Segment

Other Inventory Turnover Ratios
Qiagen N V 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
QGEN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for QGEN's Competitors
Inventory Turnover Ratio for QGEN's Suppliers
Inventory Turnover Ratio for QGEN's Customers

You may also want to know
QGEN's Sales Growth Rates QGEN's Pe Price to earnings ratio QGEN's Receivables Turnover Ratio QGEN's Stock Quote
QGEN's Net Income Growth Rates QGEN's Ps Price to Sales ratio QGEN's Sales per Employee QGEN's Asset Turnover Ratio
QGEN's Net Margin QGEN's Pb Price to Book ratio QGEN's Financial Strength Ratios QGEN's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2025 Inventories at quarter ending Dec 31 2025
Irhythm Holdings Inc   11.85 $ 219.000  Millions$ 18  Millions
Edap Tms Sa  11.73 $ 95.511  Millions$ 8  Millions
Infusystem Holdings Inc  11.10 $ 63.140  Millions$ 6  Millions
Option Care Health Inc   10.99 $ 4,561.000  Millions$ 415  Millions
Hutchmed china Limited  10.77 $ 336.349  Millions$ 31  Millions
Genedx Holdings Corp   10.51 $ 129.000  Millions$ 12  Millions
Star Equity Holdings Inc   10.28 $ 87.159  Millions$ 8  Millions
Earth Science Tech Inc   9.97 $ 7.141  Millions$ 1  Millions
Zevra Therapeutics Inc   9.73 $ 16.482  Millions$ 2  Millions
Nutriband Inc   9.68 $ 1.470  Millions$ 0  Millions
Nano X Imaging Ltd  9.44 $ 25.809  Millions$ 3  Millions
Concord Medical Services Holdings Ltd  9.43 $ 62.160  Millions$ 7  Millions
Lantheus Holdings Inc   9.29 $ 599.000  Millions$ 64  Millions
Carlsmed Inc   9.23 $ 12.110  Millions$ 1  Millions
National Vision Holdings Inc   9.22 $ 819.469  Millions$ 89  Millions
Sotera Health Company  9.20 $ 518.000  Millions$ 56  Millions
Alnylam Pharmaceuticals Inc   9.17 $ 677.166  Millions$ 74  Millions
Tarsus Pharmaceuticals Inc   9.11 $ 33.679  Millions$ 4  Millions
Warby Parker Inc   8.81 $ 401.000  Millions$ 45  Millions
Lifemd Inc   8.69 $ 27.000  Millions$ 3  Millions
Castle Biosciences Inc   8.33 $ 71.028  Millions$ 9  Millions
Myriad Genetics Inc   8.29 $ 247.000  Millions$ 30  Millions
Cardiff Lexington Corporation  8.23 $ 4.442  Millions$ 1  Millions
Collegium Pharmaceutical Inc   8.19 $ 316.071  Millions$ 39  Millions
Charles River Laboratories International inc   7.90 $ 2,314.760  Millions$ 293  Millions
Pulse Biosciences Inc   7.87 $ 0.539  Millions$ 0  Millions
Adaptive Biotechnologies Corporation  7.75 $ 71.359  Millions$ 9  Millions
Inogen Inc   7.65 $ 194.403  Millions$ 25  Millions
Casi Pharmaceuticals inc   7.55 $ 10.636  Millions$ 1  Millions
Puma Biotechnology Inc   7.19 $ 58.157  Millions$ 8  Millions

Date modified: 2026-07-07T12:43:35+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.